IgA nephropathy trials in Italy

In Italy 12 Also abroad 92

12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Where
Bari, Bologna, Brescia, Genoa, Messina, Milan, Pavia, Piacenza, Turin
Age
18 years and over
People
347 worldwide
Run by
Takeda
See details and how to joinNCT06963827 · EU 2025-520825-19-00
Phase 3Taking people
A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials
Where
Bari, Modena, Naples, Pavia, Rome, Trieste
Age
18 years and over
People
69 worldwide
Run by
Novartis Pharma AG
See details and how to join2024-519638-22-00 · EU 2024-519638-22-00
Phase 2Taking people
A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN
Where
Bologna, Como, Parma, Rome
Age
18 years and over
People
120 worldwide
Run by
argenx
See details and how to joinNCT07773727 · EU 2026-525638-43-00
Phase 2Taking people
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Where
Brescia, Pavia, Ranica
Age
18 years and over
People
32 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07146906 · EU 2024-519699-24-00
Phase 2Taking people
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Where
Bergamo, Bologna, Pavia
Age
18 years and over
People
45 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06989359
Phase 3Taking people
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Where
Bari, Brescia, Eboli, Milan, Modena, Parma, Piacenza, Ranica, Rozzano, Trieste, Turin
Age
18 years and over
People
454 worldwide
Run by
Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00
Phase 3Not yet taking people in Italy
An open-label, single-arm, multicenter roll-over extension program (REP) to characterize the long-term safety and tolerability of iptacopan (LNP023) in patients who have completed a clinical trial (parent study) in the iptacopan pediatric program.
Where
Genoa
Age
Up to 17 years
People
1
Run by
Novartis Pharma AG
See details and how to join2026-525677-39-00 · EU 2026-525677-39-00
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Bologna, Naples
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
Study of Ravulizumab in Pediatric Participants With Primary IgAN
Where
Genoa, Rome, Turin
Age
2 years to 18 years
People
36 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07024563 · EU 2024-520167-13-00
Phase 2Taking people
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Where
Bari, Genoa, Milan, Padova, Rome
Age
1 year to 17 years
People
67 worldwide
Run by
Travere Therapeutics, Inc.
See details and how to joinNCT05003986 · EU 2023-505497-14-00
Phase 2/3Enrolling by invitation
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
Where
Bologna, Genova, Pavia, Piacenza
Age
18 years and over
People
600 worldwide
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659
Phase 4Taking people
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
Where
Acquaviva delle Fonti, Bagno a Ripoli, Bologna, Bolzano, Brescia, Brindisi, Cagliari, Catania, Catanzaro, Chieti, Cosenza, Cuneo, Eboli, Ferrara, Florence, Foggia, Forlì, Genoa, Latina, Lecce, Lecco, Messina, Milan, Milano, Modena, Modica, Monza, Novara, Ostia Lido (Roma), Palermo, Parma, Pavia, Perugua, Pisa, Ravenna, Reggio Calabria, Reggio Emilia, Rimini, Roma, Rome, Rozzano, San Giovanni Rotondo, Turin, Udine, Viterbo, Ospedale San Giovanni di Dio, Azienda USL Toscana Sud Est -Ospedale Misericordia - Grosseto, Ospedale di Prato Santo Stefano
Age
18 years and over
People
878
Run by
Fondazione Schena
See details and how to joinNCT04662723 · EU 2024-517861-18-00